{"nctId":"NCT00687908","briefTitle":"Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance","startDateStruct":{"date":"2008-11"},"conditions":["Acne"],"count":243,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Vehicle Gel"]}],"interventions":[{"name":"Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel","otherNames":["Adapalene-BPO gel"]},{"name":"Vehicle Gel","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who completed the previous study (RD.03.SPR29074 - NCT00688064)and had obtained at least a good Improvement (Grade, 0, 1, 2 or 3)\n\nExclusion Criteria:\n\n* Female Subjects who are pregnant, nursing or planning a pregnancy during the study\n* Subjects who foresee intensive UV exposure during the study (mountain sports, UV radiation, sunbathing, etc).","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"35 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Maintenance Success for Total Lesions at Week 24","description":"Maintenance success for total lesions at Week 24 is defined as the percentage of subjects maintaining at least 50 percent of the improvement obtained with prior combination therapy, in terms of total lesion counts.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.9","spread":null},{"groupId":"OG001","value":"45.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Maintenance Success for Inflamatory Lesions at Week 24","description":"Maintenance success for inflamatory lesions at Week 24 is defined as the percentage of subjects maintaining at least 50 percent of the improvement obtained with prior combination therapy, in terms of inflamatory lesion counts.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"48.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Maintenance Success for Non-inflammatory Lesions at Week 24","description":"Maintenance success for non-inflamatory lesions at Week 24 is defined as the percentage of subjects maintaining at least 50 percent of the improvement obtained with prior combination therapy, in terms of non-inflamatory lesion counts.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"43.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Investigator Global Assessment (IGA) Maintenance Success at Week 24","description":"IGA maintenance success is defined as the percentage of subjects with IGA grade inferior or equal to Baseline IGA grade.\n\nIGA grade:\n\n0 Clear:Residual hyperpigmentation \\& erythema may be present\n\n1. Almost Clear:A few scattered comedones \\& a few small papules.\n2. Mild:Some comedones \\& some papules and pustules. No nodules present\n3. Moderate:Many comedones, papules \\& pustules. One nodule may be present\n4. Severe:Covered with comedones, numerous papules \\& pustules \\& few nodules \\& cysts may be present\n5. Very severe:Highly inflammatory acne covering the face; with nodules \\& cysts present","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.7","spread":null},{"groupId":"OG001","value":"34.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent of Subjects With Adverse Events","description":"All participants with events were measured for that particular Outcome Measure and not only the events with a frequency threshold above 2 percent","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41.5","spread":null},{"groupId":"OG001","value":"29.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":123},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Sinusitis","Influenza"]}}}